Director/PDMR Shareholding

Hikma Pharmaceuticals PLC (the "Company")

                        Director Shareholding

                   Notification of Option Exercise


LONDON, 16 April 2008 - Hikma Pharmaceuticals PLC ("Hikma") (LSE:
HIK) (DIFX: HIK), the multinational pharmaceuticals group, announces
that on 15 April 2008 the following Director exercised his option to
purchase the number of ordinary shares of 10 pence each set out in
the table below in the capital of the Company. These options were
granted on the date shown below pursuant to the Company's 2004 Stock
Option Plan:



+-------------------------------------------------------------------+
|       Name        |    Date of Grant    |    Number of Shares     |
|                   |                     |        Exercised        |
|-------------------+---------------------+-------------------------|
| Mazen Darwazeh    |      12 October     |         160,000         |
|                   |       2004          |                         |
+-------------------------------------------------------------------+


As a result of the above transactions the Director listed below now
has the following holdings in the ordinary share capital of the
Company:


+-------------------------------------------------------------------+
| Name               | Ordinary Shares in the | Percentage of Share |
|                    | Company                | capital             |
|                    |                        |                     |
|--------------------+------------------------+---------------------|
| Mazen Darwazeh     | 777,591                | 0.412%              |
+-------------------------------------------------------------------+



The issued share capital of Hikma Pharmaceuticals PLC is now
188,486,807 ordinary shares of 10 pence each.

Date of Notification: 15 April 2008

Henry Knowles
Company Secretary
020 7399 2760

---END OF MESSAGE---